中文摘要：本发明公开了一种由弹性蛋白样多肽组成的疫苗佐剂，可提高特异性抗原免疫反应和疫苗稳定性，可用于预防和治疗相关疾病，并能提高疫苗的生物相容性。
 
外文摘要：【課題】アジュバント活性を充分に示し、且つ安全性が高いアジュバントを提供すること。【解決手段】エラスチン様ポリペプチドを含有する、アジュバント。【選択図】なし
主权项：NOVELTY - Adjuvant comprises elastin-like polypeptide.
USE - The adjuvant is useful in vaccine (claimed) for providing immune responsiveness with respect to antigens and its sustainability, and preventing or treating diseases including diphtheria, tetanus, whooping cough, polio, influenza, pneumonia, hepatitis A, hepatitis B, leukemia, tuberculosis, cholera, dysentery, typhoid, meningococcal infection, pneumococcal infection, Japanese encephalitis, yellow fever, epidemic parotitis, rabies, measles, rubella, varicella, small pox, allergic diseases, cancer, immunological diseases, blood diseases, immune system diseases, endocrine system diseases, metabolic diseases, nerve and muscular diseases, visual system diseases, auditory equilibrium function system diseases, cardiovascular diseases, respiratory diseases, digestive system diseases, skin and connective tissue diseases, bone and joint diseases, renal/urological diseases, and syndr! omes accompanied by changes in chromosomes and genes. The cancer includes cervical cancer, stomach cancer, colon cancer and malignant tumor.
ADVANTAGE - The adjuvant has increased biocompatibility.
DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for vaccine, which comprises elastin-like polypeptide and antigen.
 
申请号：JP20160043031
公开/公告号：JP2017160127A
申请日：2016-03-07
公开/公告日：2017-09-14
申请/专利权人：JSR CORP (JAPS-C)
发明/设计人：GOTO, M; SHIMOSATO, T; ENDO, T
主分类号：A61K39/00;
点击下载：一种能提高免疫反应、预防和治疗疾病的疫苗佐剂